Literature DB >> 7919344

Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium.

P Allavena1, C Paganin, D Zhou, G Bianchi, S Sozzani, A Mantovani.   

Abstract

We investigated the chemotactic activity of interleukin (IL)-12 on human natural killer (NK) cells and other leukocyte subsets. It was found that IL-12 induced directional migration of highly enriched preparations of NK cells (> 80% CD16+ and CD56+) and CD3-activated T cells (both of CD4 and CD8 subset), but not resting T cells and monocytes. On the contrary, purified polymorphonuclear cells (PMN) showed significant and reproducible chemotactic response to IL-12. The effects of IL-12 on leukocyte migration were observed in a narrow concentration range with a peak at approximately 7.5 ng/mL, and were abrogated by monoclonal antibody (MoAb) anti-IL-12 or after cytokine boiling. We also investigated the interaction of NK cells with vascular endothelium in vitro. Overnight treatment of NK cells with IL-12 augmented their binding to cultured endothelial cells (EC) obtained from umbilical veins. IL-12-increased binding was better observed when resting rather than IL-1-activated EC were used as substratum of adhesion. IL-12-augmented binding of NK cells to resting or IL-1-activated EC involved the LFA-1/ICAM-1 and VLA-4/VCAM-1 pathways. Thus, by inducing migration and interaction with EC, IL-12 regulates crucial determinants of NK-cell recruitment in tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919344

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens.

Authors:  Richard W Childs; Mattias Carlsten
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

2.  Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis.

Authors:  A M Malfait; D M Butler; D H Presky; R N Maini; F M Brennan; M Feldmann
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 3.  Leveraging natural killer cells for cancer immunotherapy.

Authors:  Steven K Grossenbacher; Ethan G Aguilar; William J Murphy
Journal:  Immunotherapy       Date:  2017-05       Impact factor: 4.196

4.  Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.

Authors:  Qingdong Guan; Yanbing Ma; China-Li Hillman; Gefei Qing; Allan G Ma; Carolyn R Weiss; Gang Zhou; Aiping Bai; Richard J Warrington; Charles N Bernstein; Zhikang Peng
Journal:  Mol Med       Date:  2011-03-11       Impact factor: 6.354

5.  Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change.

Authors:  B Bussolati; F Mariano; L Biancone; R Foà; S David; V Cambi; G Camussi
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 6.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

7.  Rapid recruitment of macrophages in interleukin-12-mediated tumour regression.

Authors:  S J Ha; S B Lee; C M Kim; H S Shin; Y C Sung
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

8.  Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes.

Authors:  L Diomede; S Sozzani; W Luini; M Algeri; L De Gioia; R Chiesa; P M Lievens; O Bugiani; G Forloni; F Tagliavini; M Salmona
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

9.  Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia.

Authors:  Tomio Matsumoto; Keisuke Hayamizu; Seiji Marubayashi; Kiyoshi Shimizu; Aki Hamamoto; Tsuyoshi Yamaguchi; Junji Hashizume; Takashi Onabe; Toshimasa Asahara; Hideki Ohdan
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

10.  An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.

Authors:  M J Smyth; J M Kelly; A G Baxter; H Körner; J D Sedgwick
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.